A Case-control study of motor neurone disease : its relation to heritability, and occupational exposures, particularly to solvents

<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
  <record>
    <leader>00000nab a2200000 i 4500</leader>
    <controlfield tag="001">MAP20071015945</controlfield>
    <controlfield tag="003">MAP</controlfield>
    <controlfield tag="005">20080418114416.0</controlfield>
    <controlfield tag="007">hzruuu---uuuu</controlfield>
    <controlfield tag="008">931201e19921101gbr||||    | |00010|eng d</controlfield>
    <datafield tag="040" ind1=" " ind2=" ">
      <subfield code="a">MAP</subfield>
      <subfield code="b">spa</subfield>
    </datafield>
    <datafield tag="084" ind1=" " ind2=" ">
      <subfield code="a">873</subfield>
    </datafield>
    <datafield tag="245" ind1="1" ind2="2">
      <subfield code="a">A Case-control study of motor neurone disease</subfield>
      <subfield code="b">: its relation to heritability, and occupational exposures, particularly to solvents</subfield>
      <subfield code="c">Lars-Gunnar Gunnarsson... [et al.]</subfield>
    </datafield>
    <datafield tag="520" ind1=" " ind2=" ">
      <subfield code="a">Motor neurone disease is a neurodegenerative disease with an inexorable progressive and fatal course. It encompasses the diagnoses of amyotrophic lateral sclerosis, progressive bulbar palsy, and progressive muscular atrophy. The aetiology is still unclear but the past two decades of research have given increasing support to the hypothesis that environmental factors may have an aetiological role. Most evidence in the respect emanates from the studies concerning amyotrophic lateral sclerosis in Guam, indicating an influence from ingested neurotoxins, glutamate, and other excitatory aminoacids or nutritional deficiencies of calcium or magnesium</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080576615</subfield>
      <subfield code="a">Medicina laboral</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080619480</subfield>
      <subfield code="a">Enfermedades profesionales</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080565541</subfield>
      <subfield code="a">Epidemiología</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080557904</subfield>
      <subfield code="a">Disolventes</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080601249</subfield>
      <subfield code="a">Enfermedades mentales</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080560317</subfield>
      <subfield code="a">Psiquiatría</subfield>
    </datafield>
    <datafield tag="700" ind1="1" ind2=" ">
      <subfield code="0">MAPA20080319632</subfield>
      <subfield code="a">Gunnarsson, Lars-Gunnar</subfield>
    </datafield>
    <datafield tag="740" ind1="0" ind2=" ">
      <subfield code="a">British journal of industrial medicine</subfield>
    </datafield>
    <datafield tag="773" ind1="0" ind2=" ">
      <subfield code="t">British journal of industrial medicine</subfield>
      <subfield code="d">London and Margate</subfield>
      <subfield code="g">nº 11, November 1992 ; p. 791-798</subfield>
    </datafield>
  </record>
</collection>